Medipass spa

Medipass spa provides advanced healthcare services specializing in integrated clinical solutions, diagnostic imaging, and treatment in radiotherapy. The company operates outpatient centers, enhancing patient care within local healthcare ecosystems in Italy. Medipass spa, founded in 1990 and headquartered in Bologna, Italy, focuses on providing integrated clinical solutions within the healthcare sector. The company was led by founder Sarel Gilshon and currently operates under CEO Jonathan Davey.

Medipass has successfully completed 2 deals, with the most recent deal occurring on September 7, 2020, when DWS Group fully acquired the company from KOS S. p. A. The acquisition enabled DWS Group to use Medipass as a platform for cancer care and diagnostic imaging services across Europe.

Medipass specializes in delivering advanced healthcare services, focusing on integrated clinical solutions, diagnostic imaging, nuclear medicine, and radiotherapy. The company operates outpatient centers that provide high-quality diagnostic imaging, radiation therapy, and specialized medical care predominantly in regions such as Tuscany and Emilia Romagna, Italy. Medipass enhances operational efficiency by partnering with public and private hospitals, utilizing innovative organizational models and technologies to improve patient outcomes. In 2023, Medipass reported a revenue of USD 416.

07 mn and an EBITDA of USD 11. 38 mn. The company generates revenue through service agreements and partnerships with public and private healthcare facilities, involving long-term partnerships that allow hospitals to outsource their diagnostic and treatment services while Medipass manages the operational aspects of these services. Medipass aims to expand its offerings by developing new healthcare products and services designed for enhanced patient care and operational efficiency.

The acquisition by DWS Group in September 2020 will be leveraged to further establish Medipass as a key player in cancer care and diagnostic imaging within Europe. The company plans to target new markets and regions for expansion, although specific locations and timelines have not been disclosed. The funding received from the acquisition has provided the necessary resources to support these initiatives and drive growth.